Bnp Paribas Asset Management Holding S.A. Biotechnology

Bnp Paribas Asset Management Holding S.A.

$41 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
REGN Regeneron Pharmaceuticals, Inc.	$60.3B	$231 Million 0.56% of portfolio	440,424	Q2 2025 Reduced 17.25%
VRTX Vertex Pharmaceuticals Inc	$94.1B	$198 Million 0.48% of portfolio	444,459	Q2 2025 Added 13.38%
JAZZ Jazz Pharmaceuticals PLC	$6.98B	$62.2 Million 0.15% of portfolio	586,425	Q2 2025 Added 6.98%
IONS Ionis Pharmaceuticals Inc	$5.91B	$53.4 Million 0.13% of portfolio	1,350,879	Q2 2025 Added 12.91%
RARE Ultragenyx Pharmaceutical Inc.	$1.93B	$52.8 Million 0.13% of portfolio	1,452,130	Q2 2025 Added 26.22%
ARGX Argenx Se	$36.6B	$48.2 Million 0.12% of portfolio	87,414	Q2 2025 Added 244.56%
ASND Ascendis Pharma A/S	$10.7B	$47.8 Million 0.12% of portfolio	276,984	Q2 2025 Reduced 16.1%
VCEL Vericel Corp	$1.71B	$47.6 Million 0.12% of portfolio	1,118,727	Q2 2025 Reduced 3.14%
PTCT Ptc Therapeutics, Inc.	$3.25B	$38.6 Million 0.09% of portfolio	789,494	Q2 2025 Added 25.58%
RPRX Royalty Pharma PLC	$16.4B	$34.5 Million 0.08% of portfolio	958,089	Q2 2025 Added 7.37%
AGIO Agios Pharmaceuticals, Inc.	$1.96B	$33.8 Million 0.08% of portfolio	1,016,891	Q2 2025 Reduced 0.86%
INSM Insmed Inc	$14.8B	$30.4 Million 0.07% of portfolio	302,065	Q2 2025 Reduced 50.75%
UTHR United Therapeutics Corp	$13.7B	$26.2 Million 0.06% of portfolio	91,117	Q2 2025 Added 50.28%
PTGX Protagonist Therapeutics, Inc	$2.51B	$24.7 Million 0.06% of portfolio	446,026	Q2 2025 Added 17.48%
CYTK Cytokinetics Inc	$3.21B	$22.3 Million 0.05% of portfolio	676,280	Q2 2025 Added 29.44%
XENE Xenon Pharmaceuticals Inc.	$2.08B	$20.7 Million 0.05% of portfolio	661,082	Q2 2025 Reduced 6.07%
CRNX Crinetics Pharmaceuticals, Inc.	$1.44B	$20.5 Million 0.05% of portfolio	712,719	Q2 2025 Added 16.68%
INCY Incyte Corp	$17.4B	$15.8 Million 0.04% of portfolio	231,306	Q2 2025 Reduced 22.86%
SNDX Syndax Pharmaceuticals Inc	$706M	$13.5 Million 0.03% of portfolio	1,445,440	Q2 2025 Added 18.36%
BMRN Biomarin Pharmaceutical Inc	$10.7B	$12.3 Million 0.03% of portfolio	223,391	Q2 2025 Added 66.4%
RCUS Arcus Biosciences, Inc.	$654M	$11.4 Million 0.03% of portfolio	1,395,726	Q2 2025 Reduced 14.27%
ALNY Alnylam Pharmaceuticals, Inc.	$54B	$10.2 Million 0.02% of portfolio	31,402	Q2 2025 Added 98.33%
BCYC Bicycle Therapeutics PLC	$227M	$7.24 Million 0.02% of portfolio	1,041,456	Q2 2025 Reduced 14.61%
IMCR Immunocore Holdings PLC	$1.4B	$4.06 Million 0.01% of portfolio	129,410	Q2 2025 Reduced 19.77%
TECH Bio Techne Corp	$1.98B	$3.18 Million 0.01% of portfolio	61,722	Q2 2025 Added 396.92%
MRNA Moderna, Inc.	$10.2B	$2.59 Million 0.01% of portfolio	93,916	Q2 2025 Reduced 22.85%
EXEL Exelixis, Inc.	$12.1B	$1.36 Million 0.0% of portfolio	30,884	Q2 2025 Added 8.77%
CORT Corcept Therapeutics Inc	$7.74B	$955,000 0.0% of portfolio	13,018	Q2 2025 Added 268.78%
LEGN Legend Biotech Corp	$6.19B	$498,000 0.0% of portfolio	14,043	Q2 2025 Reduced 2.42%
BNTX Bio N Tech Se	$27.1B	$159,000 0.0% of portfolio	1,492	Q2 2025 New
BPMC Blueprint Medicines Corp	$7.73B	$75,000 0.0% of portfolio	584	Q2 2025 Reduced 99.16%
HALO Halozyme Therapeutics, Inc.	$8.76B	$62,000 0.0% of portfolio	1,198	Q2 2025 New
PHVS Pharvaris N.V.	$679M	$57,000 0.0% of portfolio	3,261	Q2 2025 New
BBIO Bridge Bio Pharma, Inc.	$6.91B	$54,000 0.0% of portfolio	1,246	Q2 2025 New
TGTX Tg Therapeutics, Inc.	$3.88B	$49,000 0.0% of portfolio	1,357	Q2 2025 New
RVMD Revolution Medicines, Inc.	$3.07B	$47,000 0.0% of portfolio	1,276	Q2 2025 New
ADMA Adma Biologics, Inc.	$3.24B	$41,000 0.0% of portfolio	2,229	Q2 2025 New
PCVX Vaxcyte, Inc.	$1.77B	$40,000 0.0% of portfolio	1,218	Q2 2025 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.91B	$40,000 0.0% of portfolio	132	Q2 2025 New
CRSP Crispr Therapeutics Ag	$4.29B	$37,000 0.0% of portfolio	761	Q2 2025 New
AXSM Axsome Therapeutics, Inc.	$4.49B	$34,000 0.0% of portfolio	326	Q2 2025 New
VKTX Viking Therapeutics, Inc.	$2.91B	$27,000 0.0% of portfolio	1,002	Q2 2025 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.04B	$27,000 0.0% of portfolio	1,253	Q2 2025 New
RYTM Rhythm Pharmaceuticals, Inc.	$5.15B	$27,000 0.0% of portfolio	421	Q2 2025 New
AKRO Akero Therapeutics, Inc.	$2.34B	$26,000 0.0% of portfolio	492	Q2 2025 New
VCYT Veracyte, Inc.	$1.96B	$25,000 0.0% of portfolio	936	Q2 2025 New
NUVL Nuvalent, Inc.	$3.19B	$24,000 0.0% of portfolio	311	Q2 2025 New
KRYS Krystal Biotech, Inc.	$3.56B	$24,000 0.0% of portfolio	174	Q2 2025 New
RNA Avidity Biosciences, Inc.	$2.41B	$23,000 0.0% of portfolio	822	Q2 2025 New
SRRK Scholar Rock Holding Corp	$1.65B	$22,000 0.0% of portfolio	617	Q2 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.